Segmed Leverages ECR 2026 Platform To Advance Real-World Data Strategy in Medical AI

Segmed spent the week underscoring its role as a real-world imaging data and validation partner for medical AI at the European Congress of Radiology 2026 in Vienna. The company highlighted structured, de-identified multimodal datasets that support AI training, external validation, medical device development, and multicenter benchmarking across diverse patient populations.

Segmed is showcasing research on large language models for CAD-RADS scoring in cardiac imaging through a multicenter benchmarking study led by its Chief Scientific Officer. The company framed rigorous validation on real-world data as essential for trustworthy clinical AI, aligning its platform with regulatory-grade evidence requirements and hospital expectations.

The company is also collaborating with iMerit Technology and Advocate Health on an open-source, annotated 3D mammogram dataset built from biopsy-confirmed Digital Breast Tomosynthesis studies. Reviewed by U.S. board-certified radiologists and enhanced with expert lesion segmentations, the dataset is intended to lower barriers to AI research in breast cancer detection.

In parallel, Segmed is promoting an upcoming “Bytes of Innovation” session on March 10 focused on how radiology departments can build and operationalize in-house clinical AI programs. Featuring Hospital Italiano de Buenos Aires radiologist Martina Aineseder, M.D., the event will explore buy-vs-build trade-offs, evaluation and validation strategies, and workflow integration challenges.

Across these initiatives, Segmed is positioning itself less as a pure model vendor and more as a data infrastructure and implementation partner at the center of radiology AI workflows. This week’s activity suggests strategic emphasis on validation, bias mitigation, and practical deployment frameworks, which could enhance the firm’s attractiveness to clinicians, AI developers, device manufacturers, and regulators over time.

The company’s scientific visibility and business development push at ECR, coupled with ecosystem collaborations and educational outreach, may support future partnerships and customer acquisition. Overall, the week highlighted Segmed’s effort to anchor its growth around trusted real-world imaging data and responsible clinical AI adoption in high-value diagnostic domains.